Associated Papers
Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitors.
Di Maio VC et al.
Antimicrobial Agents and Chemotherapy, 2014
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women.
Dryer PD et al.
The Journal of Antimicrobial Chemotherapy, 2009
Select a paper to view details